Endo Pharmaceuticals Holdings has acquired American Medical Systems for approximately $2.9bn.

The acquisition will improve the Endo’s business risk profile through enhanced product and geographic diversity and, over the longer term, a reduced dependence on patented products.

Endo used proceeds from a $2.7bn senior secured credit facility and $900m of senior unsecured notes to fund the acquisition, refinance Endo’s existing secured debt, and pay transaction fees.

Questions remain over Endo’s significant financial risk profile. Despite significant company debt the company has shown a shift toward a more aggressive financial policy, with a tolerance for large acquisitions and higher leverage.